VIVO
Index
Log in
Search form
Menu
Home
People
Organizations
Research
Events
Phase Ii Trial of Rituxan Plus Favid (Tumor-Specific Idiotypklh) and Gm-Csf Immunotherapy in Patients W/ Grade 1 or 2...
Grant
Overview
Identity
View All
Overview
date/time interval
December 1, 2004 - May 15, 2008
awarded by
Favrille Inc
subcontracted through
University of Florida Research Foundation
Foundation
administered by
College of Medicine - Jacksonville
total award amount
56500.00
sponsor award ID
Identity
DSR Number
05101981
06010984
06030682
07012084
PeopleSoft Contract Number
00054987